Skip to content
DeepViews

Ingevity Corporation (NGVT) — Analysis Summary

Ingevity Corporation (NGVT) has a market cap of $2.37B with year-over-year revenue growth of -17.0%. Net margin stands at -14.3%. The stock trades at a P/E ratio of 44.0.

Key Takeaways

  • Revenue changed -17.0% year-over-year
  • Net margin of -14.3%
  • P/E ratio of 44.0

Compared to other companies in the CHEMICALS & ALLIED PRODUCTS sector, NGVT posted revenue growth of -17.0% and trades at a P/E of 44.0.

[XNYS]

Ingevity Corporation (NGVT)

$69.07

PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$2374.48M
Enterprise Value
$3477.28M
P/E Ratio
44.0
Div Yield
0.00%
EV/EBITDA
20.4
Company Profile
About
About Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.

Sector

CHEMICALS & ALLIED PRODUCTS

Employees

1,500

Headquarters

NORTH CHARLESTON, SC

Exchange

XNYS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
56
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$46.90M
Total Debt$1200.20M
Debt-to-Equity25.59
Cash & Equivalents$97.40M

Cash Flow

Operating Cash Flow$211.00M
Free Cash Flow$154.90M
FCF Margin14.20%
P/FCF Ratio15.33
Source: Polygon.io · SEC EDGAR
Dividends
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.